CD59 but not DAF deficiency accelerates atherosclerosis in female ApoE knockout mice

Guipeng An1, Takashi Miwa, Wen-Liang Song

  • 1Institute for Translational Medicine and Therapeutics and Department of Pharmacology, University of Pennsylvania School of Medicine, Room 1254 BRBII/III, 421 Curie Blvd, Philadelphia, PA 19104, USA.

Molecular Immunology
|March 20, 2009
PubMed

Insights

CD59, a complement regulator, protects against atherosclerosis in ApoE-deficient mice, particularly in females. DAF deficiency had no significant effect, suggesting CD59

Area of Science:

  • Immunology
  • Cardiovascular Biology
  • Complement System

Background:

  • The complement system's role in atherosclerosis is known, but membrane-bound complement regulators' specific influence remains unclear.
  • Investigating membrane-bound complement regulators like decay-accelerating factor (DAF) and CD59 is crucial for understanding atherosclerosis pathogenesis.

Purpose of the Study:

  • To elucidate the roles of DAF and CD59 in a murine model of atherosclerosis.
  • To determine if DAF or CD59 deficiency exacerbates atherosclerosis in apolipoprotein E (ApoE)-deficient mice.

Main Methods:

  • Generated DAF(-/-)ApoE(-/-) and CD59(-/-)ApoE(-/-) mice by crossing knockout mice with ApoE-deficient mice.
  • Administered a high-fat diet (HFD) for 8 or 16 weeks.
  • Assessed lesion extent using en face analysis and aortic root sectioning; performed immunohistochemistry for membrane attack complex (MAC) and collagen.

Main Results:

  • CD59 deficiency significantly increased atherosclerotic lesion size in female ApoE(-/-) mice at both 8 and 16 weeks.
  • DAF deficiency did not significantly alter atherosclerosis progression in ApoE(-/-) mice.
  • CD59 deficiency led to increased MAC deposition and collagen staining, with elevated plasma cholesterol in female mice.

Conclusions:

  • CD59, but not DAF, confers protection against atherosclerosis in the context of ApoE deficiency.
  • The protective effect of CD59 is gender-biased and likely involves preventing MAC-mediated vascular injury.
  • CD59 may also influence plasma cholesterol homeostasis, contributing to its protective role.